Analysis of Aldehyde Biomarkers of Exposure and Host Response
Status:
Unknown status
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
Analysis of aldeyde biomarkers of exposure and host response The purpose of this prospective,
open-label, clinical trial is to establish the feasibility and validity of exhaled breath
condensate (EBC) biomarkers for use in studies designed to evaluate harm reduction strategies
of smoking. This will be accomplished by measuring selected markers in EBC believed related
to the pathogenesis of lung disease before and after a smoking cessation intervention.